Policy and Practice Reviews

Published on 22 Sep 2023

Rebalancing commercial and public interests in prioritizing biomedical, social and environmental aspects of health through defining and managing conflicts of interest

Barbara K. Redman

Frontiers in Medicine

doi 10.3389/fmed.2023.1247258

146 views

Original Research

Published on 21 Sep 2023

Evaluation of medication errors in nursing during the COVID-19 pandemic and their relationship with shift work at teaching hospitals: a cross-sectional study in Iran

Abdolreza Gilavand
Negar Jafarian
Kourosh Zarea

Frontiers in Medicine

doi 10.3389/fmed.2023.1200686

139 views

Original Research

Accepted on 19 Sep 2023

Completeness of intervention description in invasive cardiology trials: an observational study of ClinicalTrials.gov registry and corresponding publications

Viktoria Lišnić
Hishaam Asraf
Marin Viđak
Ana Marušić

Frontiers in Medicine

doi 10.3389/fmed.2023.1276847

Review

Published on 19 Sep 2023

Bibliometric analysis of the current status and trends on medical hyperspectral imaging

Sijia Jiang
Ding Ma
Xin Tan
Mingyu Yang
Qingbin Jiao
Liang Xu

Frontiers in Medicine

doi 10.3389/fmed.2023.1235955

570 views

Opinion

Accepted on 18 Sep 2023

The Nexus of Social Alliances and Diverse Moral Domains: A Bedrock for Participatory Clinical Research

Johanna MC Blom
Luca Pani
VERONICA RIVI
FABIO TASCEDDA
Valentina Mantua

Frontiers in Medicine

doi 10.3389/fmed.2023.1250247

Perspective

Accepted on 15 Sep 2023

Taking AIM at Serious Illness: Implementing an Access to Investigational Medicines Expanded Access Program

Meghan Morrison Joly
Terri Edwards
Rebecca Jerome
Alex Mainor
Gordon Bernard
Jill Pulley

Frontiers in Medicine

doi 10.3389/fmed.2023.1287449

118 views

Policy and Practice Reviews

Published on 04 Sep 2023

What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements

Nevena Miletic
Sarah Adam
Jacqueline Acquah
Zainab Aziz
Angelika Joos
John M. Mwangi

Frontiers in Medicine

doi 10.3389/fmed.2023.1207954

1,426 views

Editorial

Published on 25 Aug 2023

Editorial: Managing healthcare transformation towards P5 medicine

Bernd Blobel
Dipak Kalra

Frontiers in Medicine

doi 10.3389/fmed.2023.1244100

552 views

Original Research

Published on 17 Aug 2023

Inter-rater reliability of the extended Composite Quality Score (CQS-2)

Steffen Mickenautsch
Stefan Rupf
Ivana Miletić
Ulf Tilman Strähle
Richard Sturm
Faheema Kimmie-Dhansay
Kata Vidosusić
Veerasamy Yengopal

Frontiers in Medicine

doi 10.3389/fmed.2023.1201517

286 views

Systematic Review

Published on 16 Aug 2023

Hospital length of stay prediction tools for all hospital admissions and general medicine populations: systematic review and meta-analysis

Swapna Gokhale
David Taylor
Jaskirath Gill
Yanan Hu
Nikolajs Zeps
Vincent Lequertier
Luis Prado
Helena Teede
Joanne Enticott

Frontiers in Medicine

doi 10.3389/fmed.2023.1192969

546 views

Mini Review

Published on 07 Aug 2023

Connected health in US, EU, and China: opportunities to accelerate regulation of connected health technologies to optimize their role in medicines development

Susan Awad
Lina Aljuburi
Rebecca S. Lumsden
Marya Mpandzou
Roelie Marinus

Frontiers in Medicine

doi 10.3389/fmed.2023.1248912

670 views

Perspective

Published on 26 Jul 2023

Walking the talk in digital transformation of regulatory review

Ramy Khalil
Judith C. Macdonald
Andrew Gustafson
Lina Aljuburi
Fabio Bisordi
Ginny Beakes-Read

Frontiers in Medicine

doi 10.3389/fmed.2023.1233142

1,638 views

Original Research

Published on 14 Jul 2023

Classification system for nanotechnology-enabled health products with both scientific and regulatory application

Francisco D. Rodríguez-Gómez
Oriol Penon
Dominique Monferrer
Pilar Rivera-Gil

Frontiers in Medicine

doi 10.3389/fmed.2023.1212949

489 views

Brief Research Report

Published on 11 Jul 2023

Legal medicine aspects of female sterilization: our experience

Piergiorgio Fedeli
Stefano Cecchi
Roberto Scendoni
Nunzia Cannovo

Frontiers in Medicine

doi 10.3389/fmed.2023.1198668

594 views

Review

Published on 06 Jul 2023

External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations

Patrick Silva
Nora Janjan
Kenneth S. Ramos
George Udeani
Lixian Zhong
Marcia G. Ory
Matthew Lee Smith

Frontiers in Medicine

doi 10.3389/fmed.2023.1198088

1,520 views

Original Research

Published on 06 Jul 2023

Trends in innovative pediatric drug development in China based on clinical trial registration data

Wen-Wen Wu
Xing Ji
Xin-Shuang Mou
Xin-Yue Ma
Ya-Ting Huang
Jie-Ying Zhang
Jing-Xian Zhang
Xin-Rong Xie
Ning-Ying Mao
Jing Xu

Frontiers in Medicine

doi 10.3389/fmed.2023.1187547

1,115 views

Navigation group

Articles

Rebalancing commercial and public interests in prioritizing biomedical, social and environmental aspects of health through defining and managing conflicts of interest

Evaluation of medication errors in nursing during the COVID-19 pandemic and their relationship with shift work at teaching hospitals: a cross-sectional study in Iran

Completeness of intervention description in invasive cardiology trials: an observational study of ClinicalTrials.gov registry and corresponding publications

Bibliometric analysis of the current status and trends on medical hyperspectral imaging

The Nexus of Social Alliances and Diverse Moral Domains: A Bedrock for Participatory Clinical Research

Taking AIM at Serious Illness: Implementing an Access to Investigational Medicines Expanded Access Program

What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements

Editorial: Managing healthcare transformation towards P5 medicine

Inter-rater reliability of the extended Composite Quality Score (CQS-2)

Hospital length of stay prediction tools for all hospital admissions and general medicine populations: systematic review and meta-analysis

Connected health in US, EU, and China: opportunities to accelerate regulation of connected health technologies to optimize their role in medicines development

Walking the talk in digital transformation of regulatory review

Classification system for nanotechnology-enabled health products with both scientific and regulatory application

Legal medicine aspects of female sterilization: our experience

External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations

Trends in innovative pediatric drug development in China based on clinical trial registration data